New markers for Eubacterium lentum. 1979

V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman

Of 37 strains of Eubacterium lentum and phenotypically similar organisms, 26 (70%) synthesized a corticoid 21-dehydroxylase and/or a 3 alpha-hydroxysteroid dehydrogenase. It appeared that the corticoid 3 alpha-hydroxysteroid dehydrogenase was identical to the bile acid 3 alpha-hydroxysteroid dehydrogenase. Steroid-metabolizing enzymes were found both in E. lentum and in phenotypically similar organisms. E. lentum is characterized by nitrate reduction and enhanced growth in the presence of arginine. Many phenotypically similar organisms possess either one or the other of the two markers. In contrast, using the steroid-metabolizing enzymes as markers, a "steroid-active" and a "steroid-inactive" group were established with minimal overlapping of metabolic characteristics. Synthesis of the steroid enzymes was positively correlated with production of gas from H2O2 and formation of H2S. A simple method for the detection of corticoid 21-dehydroxylase and 3 alpha-hydroxysteroid dehydrogenase, one or both of which were present in 92% of the steroid-active group, is described.

UI MeSH Term Description Entries
D003900 Desoxycorticosterone A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE 21-Hydroxyprogesterone,Cortexone,Deoxycorticosterone,Desoxycortone,11-Decorticosterone,21-Hydroxy-4-pregnene-3,20-dione,11 Decorticosterone,21 Hydroxy 4 pregnene 3,20 dione,21 Hydroxyprogesterone
D005051 Eubacterium A genus of gram-positive, rod-shaped bacteria found in cavities of man and animals, animal and plant products, infections of soft tissue, and soil. Some species may be pathogenic. No endospores are produced. The genus Eubacterium should not be confused with EUBACTERIA, one of the three domains of life. Butyribacterium
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D013250 Steroid Hydroxylases Cytochrome P-450 monooxygenases (MIXED FUNCTION OXYGENASES) that are important in steroid biosynthesis and metabolism. Steroid Hydroxylase,Steroid Monooxygenases,Hydroxylase, Steroid,Hydroxylases, Steroid,Monooxygenases, Steroid
D013255 Steroid 21-Hydroxylase An adrenal microsomal cytochrome P450 enzyme that catalyzes the 21-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP21 gene, converts progesterones to precursors of adrenal steroid hormones (CORTICOSTERONE; HYDROCORTISONE). Defects in CYP21 cause congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL). Cytochrome P-450 CYP21,Steroid 21-Monooxygenase,21-Hydroxylase,Cytochrome P-450 21-Hydroxylase,Cytochrome P-450 c21,Cytochrome P-450(c-21),Cytochrome P450c21,Progesterone 21-Hydroxylase,Steroid-21-Hydroxylase,21 Hydroxylase,Cytochrome P 450 21 Hydroxylase,Cytochrome P 450 CYP21,Cytochrome P 450 c21,P-450 c21, Cytochrome,Progesterone 21 Hydroxylase,Steroid 21 Hydroxylase,Steroid 21 Monooxygenase
D015096 3-Hydroxysteroid Dehydrogenases Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. 3-beta-Hydroxysteroid Dehydrogenase,3 Hydroxysteroid Dehydrogenases,3 beta Hydroxysteroid Dehydrogenase,Dehydrogenase, 3-beta-Hydroxysteroid,Dehydrogenases, 3 Hydroxysteroid,Dehydrogenases, 3-Hydroxysteroid,Hydroxysteroid Dehydrogenases, 3

Related Publications

V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
October 2006, Medicina clinica,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
April 1993, Journal of clinical microbiology,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
August 1976, Journal of bacteriology,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
November 1981, Applied and environmental microbiology,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
April 1987, Applied and environmental microbiology,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
March 1976, Journal of bacteriology,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
January 1988, Japanese journal of cancer research : Gann,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
December 1995, Asian Pacific journal of allergy and immunology,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
October 1990, Journal of clinical microbiology,
V D Bokkenheuser, and J Winter, and S M Finegold, and V L Sutter, and A E Ritchie, and W E Moore, and L V Holdeman
January 1984, Applied and environmental microbiology,
Copied contents to your clipboard!